Browsing Barts Cancer Institute by Subject "Multiple Myeloma"
Now showing items 1-1 of 1
-
Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma.
(2016-11)Consolidation with high-dose chemotherapy and autologous stem cell transplantation (ASCT) is the standard of care for transplantation-eligible patients with multiple myeloma, based on randomized trials showing improved ...